Pages that link to "Q38388102"
Jump to navigation
Jump to search
The following pages link to Immunotherapeutic approaches for cancer therapy: An updated review (Q38388102):
Displaying 15 items.
- Cancer immunotherapy: the beginning of the end of cancer? (Q26752277) (← links)
- The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies (Q30244095) (← links)
- ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1) (Q33772914) (← links)
- Challenges and future perspectives of T cell immunotherapy in cancer (Q35843507) (← links)
- A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells (Q37544893) (← links)
- Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model. (Q37693328) (← links)
- Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy. (Q38542764) (← links)
- Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles (Q38806325) (← links)
- Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens (Q40836206) (← links)
- Dendritic cells based immunotherapy (Q43043935) (← links)
- Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies. (Q51356582) (← links)
- Genomics of adult and pediatric solid tumors (Q58804574) (← links)
- Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine (Q90514627) (← links)
- Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine (Q90620408) (← links)
- The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors (Q92259261) (← links)